These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36288323)
1. Societal cost of nine selected maternal morbidities in the United States. O'Neil SS; Platt I; Vohra D; Pendl-Robinson E; Dehus E; Zephyrin L; Zivin K PLoS One; 2022; 17(10):e0275656. PubMed ID: 36288323 [TBL] [Abstract][Full Text] [Related]
2. Societal costs of untreated perinatal mood and anxiety disorders in Vermont. Platt IS; Pendl-Robinson EL; Dehus E; O'Neil SS; Vohra D; Kenny M; Pentenrieder L; Zivin K Arch Womens Ment Health; 2024 Aug; 27(4):585-594. PubMed ID: 38321244 [TBL] [Abstract][Full Text] [Related]
3. Financial Toll of Untreated Perinatal Mood and Anxiety Disorders Among 2017 Births in the United States. Luca DL; Margiotta C; Staatz C; Garlow E; Christensen A; Zivin K Am J Public Health; 2020 Jun; 110(6):888-896. PubMed ID: 32298167 [No Abstract] [Full Text] [Related]
4. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis. Sudhof LS; Shainker SA; Einerson BD Am J Obstet Gynecol; 2019 Sep; 221(3):275.e1-275.e12. PubMed ID: 31226298 [TBL] [Abstract][Full Text] [Related]
5. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study. Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559 [TBL] [Abstract][Full Text] [Related]
6. The economic burden of vision loss and eye disorders among the United States population younger than 40 years. Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB; Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946 [TBL] [Abstract][Full Text] [Related]
7. Cost of disorders of the brain in Europe 2010. Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J; Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589 [TBL] [Abstract][Full Text] [Related]
8. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300 [TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid for the treatment of postpartum hemorrhage: a cost-effectiveness analysis. Howard DC; Jones AE; Skeith A; Lai J; D'Souza R; Caughey AB Am J Obstet Gynecol MFM; 2022 May; 4(3):100588. PubMed ID: 35124299 [TBL] [Abstract][Full Text] [Related]
10. The economic impact of untreated maternal mental health conditions in Texas. Margiotta C; Gao J; O'Neil S; Vohra D; Zivin K BMC Pregnancy Childbirth; 2022 Sep; 22(1):700. PubMed ID: 36096759 [TBL] [Abstract][Full Text] [Related]
11. Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. Schein J; Adler LA; Childress A; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Cloutier M; Guérin A; Lefebvre P J Manag Care Spec Pharm; 2022 Feb; 28(2):168-179. PubMed ID: 34806909 [No Abstract] [Full Text] [Related]
12. In vitro fertilization and multiple pregnancies: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488 [TBL] [Abstract][Full Text] [Related]
13. Short-term costs of preeclampsia to the United States health care system. Stevens W; Shih T; Incerti D; Ton TGN; Lee HC; Peneva D; Macones GA; Sibai BM; Jena AB Am J Obstet Gynecol; 2017 Sep; 217(3):237-248.e16. PubMed ID: 28708975 [TBL] [Abstract][Full Text] [Related]
14. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990 [TBL] [Abstract][Full Text] [Related]
15. Social and economic cost of eating disorders in the United States: Evidence to inform policy action. Streatfeild J; Hickson J; Austin SB; Hutcheson R; Kandel JS; Lampert JG; Myers EM; Richmond TK; Samnaliev M; Velasquez K; Weissman RS; Pezzullo L Int J Eat Disord; 2021 May; 54(5):851-868. PubMed ID: 33655603 [TBL] [Abstract][Full Text] [Related]
16. Academic achievement and productivity losses associated with speech, language and communication needs. Cronin P; Reeve R; McCabe P; Viney R; Goodall S Int J Lang Commun Disord; 2020 Sep; 55(5):734-750. PubMed ID: 32687245 [TBL] [Abstract][Full Text] [Related]
17. The current and projected economic burden of Parkinson's disease in the United States. Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720 [TBL] [Abstract][Full Text] [Related]
18. The Economic Burden of Asthma in the United States, 2008-2013. Nurmagambetov T; Kuwahara R; Garbe P Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930 [TBL] [Abstract][Full Text] [Related]
19. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561 [TBL] [Abstract][Full Text] [Related]
20. Cost of schizophrenia in England. Mangalore R; Knapp M J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]